TREACE MED CONCEPTS INC shareholders Q1 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Allspring Global Investments Holdings, LLC 669,448$16,863,3950.03%
LORD, ABBETT & CO. LLC 292,461$7,3670.03%
Sandia Investment Management LP 5,000$125,9500.02%
Calamos Advisors LLC 179,642$4,525,1820.02%
Walleye Capital LLC 54,869$1,382,1500.02%
Russell Investments Group, Ltd. 331,229$8,343,6550.02%
Cubist Systematic Strategies, LLC 102,621$2,585,0230.02%
GABELLI FUNDS LLC 76,293$1,921,8210.02%
MARSHALL WACE, LLP 282,905$7,126,3750.02%
PUTNAM INVESTMENTS LLC 234,765$5,913,7300.01%
SEI INVESTMENTS CO 184,017$4,635,3880.01%
TWO SIGMA INVESTMENTS, LP 109,542$2,759,3630.01%
TD Capital Management LLC 2,490$62,7230.01%
Squarepoint Ops LLC 63,834$1,607,9780.01%
NORGES BANK 1,005,992$25,340,9380.01%
Graham Capital Management, L.P. 8,400$211,5960.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 442,353$11,142,8720.01%
Schonfeld Strategic Advisors LLC 21,300$536,5470.01%
MILLENNIUM MANAGEMENT LLC 312,751$7,8780.01%
MCF Advisors LLC 1,963$49,4480.01%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q1 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.